Methods for inhibiting cancer, scar formation, disrupting the cellular cytoskeleton, and conferring resistance from infection are disclosed. Such methods comprise the administration of oleuropein and/or the products of its hydrolysis in therapeutically effective amounts. To that end, a variety of pharmaceutical formulations and routes or administration are disclosed and may be utilized to treat a wide variety of diseases.

H2RC Corporation

Methods for inhibiting cancer and scar formation

Compositions comprising hydroxytyrosol-containing formulations and treatment regiments comprising hydroxytyrosol and/or oleuropein and chemotherapeutic agents are disclosed. Compositions and/or regiments may optionally include the administration of vitamins, minerals, and anti-oxidants. Methods for using these compositions and treatment regimens for treating subjects for diseases, such as a malignancy, and for inducing or enhancing angiogenesis, treating or preventing oxidative stress, for treating or preventing high glucose-induced dysfunction, treating or preventing chemotherapy-induced dysfunction, and for improving cell viability are provided. Various methods for use of the hydroxytyrosol compositions for inhibition of lysine specific demethylase 1 (LSD1) in various cancers are also provided.

McCord; Darlene E.

oleuropein/krabbamein

Methods for inhibiting cancer and scar formation

Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD1 inhibition

Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD1 inhibition

Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD1 inhibition

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum